| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 37 | 2025 | 558 | 6.470 |
Why?
|
| Induced Pluripotent Stem Cells | 16 | 2026 | 147 | 5.030 |
Why?
|
| Staphylococcal Infections | 20 | 2016 | 287 | 2.760 |
Why?
|
| Staphylococcus aureus | 18 | 2016 | 292 | 2.740 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2026 | 2579 | 2.680 |
Why?
|
| Genome-Wide Association Study | 36 | 2026 | 1859 | 2.570 |
Why?
|
| Neurons | 13 | 2026 | 1626 | 1.910 |
Why?
|
| Alleles | 9 | 2025 | 1163 | 1.800 |
Why?
|
| Lipid Droplets | 2 | 2025 | 21 | 1.790 |
Why?
|
| Genetic Loci | 7 | 2025 | 263 | 1.680 |
Why?
|
| Chromatin | 5 | 2026 | 461 | 1.670 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2026 | 2574 | 1.670 |
Why?
|
| Microglia | 5 | 2025 | 131 | 1.630 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 649 | 1.470 |
Why?
|
| Gene Expression Regulation | 9 | 2026 | 2023 | 1.460 |
Why?
|
| Mental Disorders | 7 | 2024 | 487 | 1.230 |
Why?
|
| Staphylococcal Protein A | 8 | 2016 | 44 | 1.220 |
Why?
|
| Genetic Variation | 11 | 2018 | 1454 | 1.050 |
Why?
|
| Brain Diseases | 2 | 2026 | 178 | 0.990 |
Why?
|
| Staphylococcal Vaccines | 5 | 2014 | 17 | 0.970 |
Why?
|
| Transcriptome | 7 | 2026 | 824 | 0.940 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2025 | 3 | 0.920 |
Why?
|
| Clusterin | 1 | 2025 | 13 | 0.890 |
Why?
|
| Neuroglia | 1 | 2025 | 78 | 0.860 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 53 | 0.830 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2024 | 66 | 0.820 |
Why?
|
| Cell Communication | 1 | 2025 | 223 | 0.820 |
Why?
|
| Antibodies, Bacterial | 8 | 2016 | 106 | 0.790 |
Why?
|
| Bipolar Disorder | 5 | 2014 | 412 | 0.760 |
Why?
|
| Virulence Factors | 6 | 2016 | 117 | 0.700 |
Why?
|
| Humans | 83 | 2026 | 98363 | 0.680 |
Why?
|
| MicroRNAs | 3 | 2017 | 608 | 0.680 |
Why?
|
| Coagulase | 5 | 2016 | 29 | 0.680 |
Why?
|
| DNA Copy Number Variations | 8 | 2022 | 206 | 0.650 |
Why?
|
| Astrocytes | 3 | 2025 | 142 | 0.640 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 132 | 0.640 |
Why?
|
| Brain | 5 | 2020 | 2439 | 0.630 |
Why?
|
| Behavior, Addictive | 2 | 2021 | 140 | 0.620 |
Why?
|
| Nicotine | 2 | 2021 | 218 | 0.610 |
Why?
|
| Immune Evasion | 5 | 2015 | 37 | 0.580 |
Why?
|
| Dopamine Antagonists | 1 | 2018 | 33 | 0.560 |
Why?
|
| Neural Stem Cells | 2 | 2019 | 73 | 0.550 |
Why?
|
| Phagocytosis | 4 | 2025 | 118 | 0.550 |
Why?
|
| Animals | 35 | 2025 | 28981 | 0.540 |
Why?
|
| Mice, Inbred BALB C | 15 | 2016 | 1110 | 0.520 |
Why?
|
| Neurogenesis | 1 | 2018 | 93 | 0.500 |
Why?
|
| Nervous System | 1 | 2017 | 92 | 0.490 |
Why?
|
| Abscess | 5 | 2012 | 94 | 0.480 |
Why?
|
| Bacteremia | 3 | 2016 | 110 | 0.480 |
Why?
|
| Multifactorial Inheritance | 5 | 2024 | 236 | 0.460 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2014 | 57 | 0.450 |
Why?
|
| Genome, Human | 6 | 2017 | 834 | 0.450 |
Why?
|
| Autism Spectrum Disorder | 3 | 2025 | 97 | 0.440 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2014 | 85 | 0.420 |
Why?
|
| CRISPR-Cas Systems | 3 | 2025 | 114 | 0.420 |
Why?
|
| Dopaminergic Neurons | 1 | 2014 | 32 | 0.400 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 41 | 0.400 |
Why?
|
| Cholesterol | 2 | 2026 | 376 | 0.400 |
Why?
|
| Gene Regulatory Networks | 5 | 2019 | 340 | 0.390 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 38 | 0.380 |
Why?
|
| Apoptosis | 2 | 2018 | 1752 | 0.380 |
Why?
|
| Mice | 21 | 2025 | 12735 | 0.380 |
Why?
|
| Smoking | 4 | 2017 | 676 | 0.370 |
Why?
|
| Gene Editing | 2 | 2024 | 58 | 0.370 |
Why?
|
| Ethanol | 2 | 2025 | 282 | 0.360 |
Why?
|
| Bacterial Proteins | 5 | 2016 | 901 | 0.360 |
Why?
|
| Carrier Proteins | 4 | 2018 | 670 | 0.360 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2013 | 195 | 0.360 |
Why?
|
| Synapses | 4 | 2025 | 281 | 0.350 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2016 | 213 | 0.350 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 589 | 0.340 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2070 | 0.320 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 2577 | 0.310 |
Why?
|
| Base Sequence | 5 | 2017 | 2224 | 0.310 |
Why?
|
| Codon, Nonsense | 2 | 2024 | 49 | 0.300 |
Why?
|
| Case-Control Studies | 11 | 2024 | 2009 | 0.300 |
Why?
|
| Mutation | 8 | 2025 | 4428 | 0.300 |
Why?
|
| Female | 34 | 2025 | 51756 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2006 | 83 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 755 | 0.280 |
Why?
|
| Neuronal Plasticity | 2 | 2025 | 200 | 0.280 |
Why?
|
| Antigens, Bacterial | 3 | 2011 | 135 | 0.280 |
Why?
|
| Fibrin | 3 | 2016 | 86 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2009 | 127 | 0.280 |
Why?
|
| RNA | 1 | 2013 | 596 | 0.270 |
Why?
|
| RNA Stability | 2 | 2013 | 98 | 0.270 |
Why?
|
| Hemolysin Proteins | 2 | 2012 | 32 | 0.270 |
Why?
|
| Tobacco Use Disorder | 2 | 2013 | 130 | 0.260 |
Why?
|
| Risk | 3 | 2020 | 660 | 0.260 |
Why?
|
| Bacterial Toxins | 2 | 2012 | 112 | 0.260 |
Why?
|
| Virulence | 6 | 2016 | 280 | 0.260 |
Why?
|
| Genotype | 8 | 2016 | 1892 | 0.260 |
Why?
|
| Agglutination | 4 | 2016 | 16 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 4 | 2016 | 1419 | 0.250 |
Why?
|
| Staphylococcus | 1 | 2016 | 24 | 0.250 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2020 | 299 | 0.250 |
Why?
|
| Risk Factors | 8 | 2024 | 6271 | 0.240 |
Why?
|
| Dendrites | 2 | 2017 | 101 | 0.240 |
Why?
|
| Quantitative Trait Loci | 4 | 2020 | 665 | 0.240 |
Why?
|
| Linkage Disequilibrium | 7 | 2016 | 484 | 0.240 |
Why?
|
| Phenotype | 7 | 2021 | 2667 | 0.230 |
Why?
|
| Cell Differentiation | 3 | 2018 | 1647 | 0.230 |
Why?
|
| Male | 26 | 2025 | 47257 | 0.230 |
Why?
|
| Age of Onset | 4 | 2013 | 369 | 0.230 |
Why?
|
| Signal Transduction | 3 | 2015 | 3633 | 0.220 |
Why?
|
| Adaptive Immunity | 2 | 2014 | 194 | 0.220 |
Why?
|
| Exploratory Behavior | 1 | 2025 | 48 | 0.220 |
Why?
|
| Myelin Sheath | 1 | 2025 | 69 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 143 | 0.220 |
Why?
|
| Cullin Proteins | 1 | 2024 | 9 | 0.210 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 2897 | 0.210 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2024 | 11 | 0.210 |
Why?
|
| Leukopenia | 1 | 2014 | 66 | 0.210 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2025 | 171 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 980 | 0.210 |
Why?
|
| Hydrolases | 1 | 2014 | 30 | 0.210 |
Why?
|
| Mutagenesis | 1 | 2024 | 195 | 0.210 |
Why?
|
| Ligases | 1 | 2014 | 44 | 0.200 |
Why?
|
| Microfilament Proteins | 1 | 2025 | 211 | 0.200 |
Why?
|
| Glucosyltransferases | 1 | 2013 | 26 | 0.200 |
Why?
|
| Acetylglucosamine | 1 | 2013 | 18 | 0.200 |
Why?
|
| Family | 1 | 2005 | 329 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 251 | 0.200 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 79 | 0.200 |
Why?
|
| Codon | 1 | 2003 | 116 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 446 | 0.190 |
Why?
|
| Receptors, Dopamine | 1 | 2003 | 32 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2017 | 1721 | 0.190 |
Why?
|
| Lipids | 1 | 2024 | 295 | 0.190 |
Why?
|
| Alcoholism | 1 | 2024 | 200 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2015 | 867 | 0.180 |
Why?
|
| ADAM Proteins | 1 | 2012 | 11 | 0.180 |
Why?
|
| DNA Methylation | 3 | 2017 | 735 | 0.180 |
Why?
|
| Prefrontal Cortex | 2 | 2025 | 161 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 420 | 0.170 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 100 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 209 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2004 | 832 | 0.170 |
Why?
|
| Chromosome Mapping | 6 | 2015 | 1064 | 0.170 |
Why?
|
| Dopamine | 2 | 2018 | 280 | 0.170 |
Why?
|
| Rats, Inbred F344 | 1 | 2021 | 161 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 917 | 0.160 |
Why?
|
| Haplotypes | 4 | 2008 | 657 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 317 | 0.160 |
Why?
|
| Body Height | 2 | 2010 | 109 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 317 | 0.150 |
Why?
|
| Cricetulus | 2 | 2014 | 123 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 272 | 0.150 |
Why?
|
| Neuroepithelial Cells | 1 | 2019 | 4 | 0.150 |
Why?
|
| Chromosome Duplication | 2 | 2016 | 8 | 0.150 |
Why?
|
| Transcription Factor 4 | 1 | 2019 | 13 | 0.150 |
Why?
|
| Models, Genetic | 3 | 2016 | 1006 | 0.150 |
Why?
|
| CHO Cells | 2 | 2014 | 188 | 0.150 |
Why?
|
| Olfactory Mucosa | 1 | 2019 | 33 | 0.150 |
Why?
|
| Protein Binding | 3 | 2017 | 1561 | 0.150 |
Why?
|
| CpG Islands | 2 | 2017 | 177 | 0.150 |
Why?
|
| Cell Line | 3 | 2018 | 2483 | 0.150 |
Why?
|
| Databases, Genetic | 2 | 2015 | 289 | 0.150 |
Why?
|
| Cricetinae | 2 | 2014 | 533 | 0.140 |
Why?
|
| Half-Life | 2 | 2013 | 89 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1334 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2012 | 502 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 58 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 3616 | 0.130 |
Why?
|
| Kidney | 3 | 2014 | 1121 | 0.130 |
Why?
|
| Adult | 16 | 2019 | 29587 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2017 | 1290 | 0.130 |
Why?
|
| Obesity | 2 | 2013 | 1077 | 0.130 |
Why?
|
| DNA Footprinting | 1 | 2017 | 16 | 0.130 |
Why?
|
| Inheritance Patterns | 2 | 2014 | 55 | 0.130 |
Why?
|
| Antibodies | 3 | 2025 | 349 | 0.130 |
Why?
|
| Body Size | 2 | 2015 | 103 | 0.130 |
Why?
|
| Rats | 2 | 2021 | 4074 | 0.130 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 2471 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 526 | 0.120 |
Why?
|
| Paternal Inheritance | 1 | 2016 | 4 | 0.120 |
Why?
|
| Prader-Willi Syndrome | 1 | 2016 | 8 | 0.120 |
Why?
|
| Angelman Syndrome | 1 | 2016 | 7 | 0.120 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 39 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2025 | 2858 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2016 | 66 | 0.120 |
Why?
|
| Genomics | 3 | 2022 | 903 | 0.120 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 85 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2016 | 471 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2014 | 716 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2014 | 726 | 0.110 |
Why?
|
| Peptidoglycan | 2 | 2016 | 30 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 48 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 48 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 80 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2014 | 118 | 0.100 |
Why?
|
| Homosexuality, Male | 1 | 2017 | 342 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 76 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2011 | 55 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2014 | 277 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 105 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2014 | 136 | 0.100 |
Why?
|
| Autistic Disorder | 2 | 2016 | 157 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 191 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2013 | 7 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 335 | 0.100 |
Why?
|
| Gene Expression | 2 | 2010 | 1322 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2013 | 81 | 0.100 |
Why?
|
| Immunity | 1 | 2014 | 161 | 0.100 |
Why?
|
| Base Composition | 1 | 2013 | 36 | 0.100 |
Why?
|
| HapMap Project | 1 | 2013 | 47 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 229 | 0.090 |
Why?
|
| Histones | 1 | 2015 | 364 | 0.090 |
Why?
|
| Peritonitis | 1 | 2012 | 28 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1791 | 0.090 |
Why?
|
| Schizophrenic Psychology | 1 | 2012 | 143 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2011 | 65 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 3 | 2013 | 175 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 134 | 0.090 |
Why?
|
| B-Lymphocytes | 3 | 2014 | 731 | 0.080 |
Why?
|
| Iron | 1 | 2011 | 178 | 0.080 |
Why?
|
| Lung | 2 | 2017 | 1408 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2013 | 890 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2024 | 1147 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 573 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 2008 | 0.080 |
Why?
|
| Adoption | 1 | 2010 | 9 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 218 | 0.080 |
Why?
|
| Pedigree | 3 | 2012 | 987 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 3 | 2014 | 250 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 102 | 0.080 |
Why?
|
| Twins | 1 | 2010 | 64 | 0.080 |
Why?
|
| Middle Aged | 9 | 2018 | 29532 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 65 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 1214 | 0.070 |
Why?
|
| Narcolepsy | 1 | 2009 | 11 | 0.070 |
Why?
|
| Logistic Models | 1 | 2013 | 1276 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 456 | 0.070 |
Why?
|
| Epigenomics | 2 | 2022 | 111 | 0.070 |
Why?
|
| Homeostasis | 1 | 2011 | 474 | 0.070 |
Why?
|
| Neuregulin-1 | 2 | 2006 | 17 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2016 | 733 | 0.070 |
Why?
|
| Computational Biology | 1 | 2013 | 618 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 117 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2896 | 0.070 |
Why?
|
| Environment | 1 | 2010 | 233 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 118 | 0.070 |
Why?
|
| Rabbits | 2 | 2014 | 582 | 0.070 |
Why?
|
| Internet | 1 | 2010 | 359 | 0.060 |
Why?
|
| Dysbindin | 1 | 2007 | 2 | 0.060 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 2 | 0.060 |
Why?
|
| Adolescent | 7 | 2018 | 10137 | 0.060 |
Why?
|
| Sepsis | 1 | 2011 | 402 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2016 | 73 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 21844 | 0.060 |
Why?
|
| Opsonin Proteins | 1 | 2016 | 6 | 0.060 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.060 |
Why?
|
| Genetics, Population | 2 | 2024 | 450 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 106 | 0.060 |
Why?
|
| Complement C1q | 1 | 2025 | 13 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2016 | 173 | 0.060 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2025 | 23 | 0.060 |
Why?
|
| Pseudogenes | 1 | 2025 | 39 | 0.060 |
Why?
|
| Complement Activation | 1 | 2015 | 88 | 0.060 |
Why?
|
| Meningitis, Bacterial | 1 | 2014 | 9 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 78 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1568 | 0.050 |
Why?
|
| Child | 2 | 2013 | 7745 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2024 | 175 | 0.050 |
Why?
|
| Teichoic Acids | 1 | 2014 | 18 | 0.050 |
Why?
|
| GC Rich Sequence | 1 | 2003 | 9 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2003 | 32 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2017 | 51 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 7418 | 0.050 |
Why?
|
| Iceland | 1 | 2013 | 21 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 284 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 87 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2014 | 100 | 0.050 |
Why?
|
| Cell Wall | 1 | 2014 | 72 | 0.050 |
Why?
|
| Glycosylation | 1 | 2013 | 142 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2014 | 526 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2014 | 374 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 176 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 34 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 554 | 0.050 |
Why?
|
| Gene-Environment Interaction | 2 | 2015 | 125 | 0.050 |
Why?
|
| Psychopharmacology | 1 | 2002 | 26 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 889 | 0.050 |
Why?
|
| Social Behavior | 1 | 2025 | 316 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2012 | 8 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 822 | 0.050 |
Why?
|
| Young Adult | 4 | 2018 | 7568 | 0.040 |
Why?
|
| Superantigens | 1 | 2011 | 24 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2011 | 87 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2003 | 348 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 154 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2014 | 1529 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 215 | 0.040 |
Why?
|
| Immunization, Passive | 2 | 2011 | 69 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 313 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 49 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 582 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 393 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2003 | 743 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2011 | 180 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 565 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2014 | 482 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2212 | 0.040 |
Why?
|
| Europe | 2 | 2012 | 357 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 280 | 0.040 |
Why?
|
| Kidney Diseases | 2 | 2012 | 313 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 508 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2010 | 353 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 373 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 1019 | 0.040 |
Why?
|
| Adenosine | 1 | 2011 | 291 | 0.030 |
Why?
|
| Recurrence | 1 | 2011 | 1264 | 0.030 |
Why?
|
| Machine Learning | 1 | 2022 | 410 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2017 | 51 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1203 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 30 | 0.030 |
Why?
|
| Receptors, Thyrotropin | 1 | 2017 | 48 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2017 | 12 | 0.030 |
Why?
|
| A549 Cells | 1 | 2017 | 53 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 135 | 0.030 |
Why?
|
| DNA | 1 | 2002 | 1275 | 0.030 |
Why?
|
| Italy | 1 | 2016 | 113 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 55 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 68 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 171 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 32 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 54 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1817 | 0.030 |
Why?
|
| Exome | 1 | 2016 | 149 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 23 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Neuropil | 1 | 2014 | 9 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 5576 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 107 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 84 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2014 | 27 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2014 | 87 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 1805 | 0.030 |
Why?
|
| Germinal Center | 1 | 2014 | 69 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 220 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2014 | 91 | 0.030 |
Why?
|
| Siblings | 1 | 2014 | 113 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2017 | 449 | 0.030 |
Why?
|
| Sweden | 1 | 2013 | 49 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 72 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 80 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 95 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2015 | 352 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 722 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2012 | 47 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 119 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2012 | 28 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2012 | 125 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 719 | 0.020 |
Why?
|
| United States | 1 | 2005 | 8258 | 0.020 |
Why?
|
| Coagulants | 1 | 2011 | 5 | 0.020 |
Why?
|
| Antithrombins | 1 | 2011 | 20 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1255 | 0.020 |
Why?
|
| Breast | 1 | 2014 | 316 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 43 | 0.020 |
Why?
|
| Longevity | 1 | 2011 | 64 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 9770 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1607 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1974 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 316 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 4044 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 313 | 0.020 |
Why?
|
| Self-Assessment | 1 | 2010 | 45 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 99 | 0.020 |
Why?
|
| Heme | 1 | 2010 | 66 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2010 | 116 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2012 | 284 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2056 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2010 | 197 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2009 | 41 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1296 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 89 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2009 | 82 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 527 | 0.020 |
Why?
|
| DNA Replication | 1 | 2009 | 169 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 3227 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 578 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1775 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 642 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 131 | 0.020 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2008 | 69 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2017 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2013 | 859 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 1393 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 242 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2006 | 613 | 0.010 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2002 | 8 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3612 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 11039 | 0.010 |
Why?
|